Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01905839 · ClinicalTrials.gov registry record
A Study of Movement Disorders Using the QMAT At-Home Testing Device
A clinical trial, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Terminated
- Registry status
- 3
- Enrollment target
NCT01905839: Clinical Trial study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
NCT01905839 is a clinical trial that was terminated before completion, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01905839 was terminated before completion, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
Background: \- Parkinson s disease (PD) affects half a million Americans, causing slow movements, tremors, stiffness, and trouble walking. Currently, these symptoms are measured by physical exam, but this is unreliable and requires an office visit. Researchers want to study a different way to measure PD symptoms, using a home-testing machine called a QMAT device. It can test how quickly someone moves doing different tasks. Researchers will study how this testing compares to physical exam testing and whether the device can detect changes in PD symptoms over time. Objectives: \- To see if a home testing device can be used to evaluate Parkinson s disease symptoms. Eligibility: \- Adults at least 18 years old with PD. Design: * Participants will have about 22 clinic visits over 5 years. Each visit will take up to 3 hours. Visits will be scheduled along with visits for another study. * At visit 1, participants will learn to use the QMAT device and how to send testing information to the clinic by computer. The device has a computer screen, some buttons, and some pegs. Participants will get a device to take home and any accessories. * Participants will learn 2 QMAT tests. For one, they will press keys as fast as possible. For the other, they will move pegs into holes. The tests will take a total of about 20 minutes. * Participants will take both tests at home, 2 times on the same day each week, once before their medication, once after. * A study coordinator will monitor the participant s computer data and discuss the at-home testing at the clinic visits.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2013-06-18 |
| Est. Completion | 2015-04-15 |
Why NCT01905839 stopped before completion
NCT01905839 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01905839 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01905839 about?
NCT01905839 is a clinical study titled "A Study of Movement Disorders Using the QMAT At-Home Testing Device". Background: \- Parkinson s disease (PD) affects half a million Americans, causing slow movements, tremors, stiffness, and trouble walking. Currently, these symptoms are measured by physical exam, but this is unreliable and requires an office visit. Researchers want to study a different way to measu...
What is the current status of trial NCT01905839?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2013-06-18. Estimated completion is 2015-04-15.
Who is sponsoring clinical trial NCT01905839?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI